Cytokines pattern after surgical radiofrequency ablation of liver colorectal metastases

Gastroenterologie Clinique et Biologique

Volumn 31, Issue 2, 2007, Pages 141-145

  Evrard, Serge ^a,d   Menetrier Caux, Christine ^b   Biota, Cathy ^b   Neaud, Véronique ^c   Mathoulin Pélissier, Simone ^a   Blay, Jean Yves ^b   Rosenbaum, Jean ^c  

^a INSTITUT BERGONIÉ   (France)

^b CENTRE LÉON BÉRARD   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 6; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; LAPAROTOMY; LIVER ANGIOGRAPHY; LIVER METASTASIS; PERITONEUM; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION; SURGICAL TECHNIQUE;

EID: 33947161156     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(07)89344-4     Document Type: Article

References (27)

1. Solbiati L, Ierace T, Goldberg SN, Sironi S, Livraghi T, Fiocca R, et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997;202:195-203.
2. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Data validation in an economic evaluation of surgery for colon cancer. Ann Surg 2004;239:818-25.
3. Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000;7:593-600.
4. Elias D, Baton O, Sideris L, Matsuhisa T, Pocard M, Lasser P. Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections. Ann Surg Oncol 2004;11:500-5.
5. Evrard S, Becouarn Y, Fonck M, Brunet R, Mathoulin-Pelissier S, Picot V. Surgical treatment of liver metastases by radiofrequency ablation, resection, or in combination. Eur J Surg Oncol 2004;30:399-406.
6. Evrard S, Mathoulin-Pelissier S. Controversies between surgical and percutaneous radiofrequency ablation. Eur J Surg Oncol 2006;32:3-5.
7. Masson S, Daveau M, Hiron M, Lyoumi S, Lebreton JP, Teniere P, et al. Differential regenerative response and expression of growth factors following hepatectomy of variable extent in rats. Liver 1999;19:312-7.
8. Uemura T, Miyazaki M, Hirai R, Matsumoto H, Ota T, Ohashi R, et al. Different expression of positive and negative regulators of hepatocyte growth in growing and shrinking hepatic lobes after portal vein branch ligation in rats. Int J Mol Med 2000;5:173-9.
9. de Jong KP, von Geusau BA, Rottier CA, Bijzet J, Limburg PC, de Vries EG, et al. Serum response of hepatocyte growth factor, insulin-like growth factor-I, interleukin-6, and acute phase proteins in patients with colorectal liver metastases treated with partial hepatectomy or cryosurgery. J Hepatol 2001;34:422-7.
10. de Jong KP, Hoedemakers RM, Fidler V, Bijzet J, Limburg PC, Peeters PM, et al. Portal and systemic serum growth factor and acute-phase response after laparotomy or partial hepatectomy in patients with colorectal liver metastases: a prognostic role for C-reactive protein and hepatocyte growth factor. Scand J Gastroenterol 2004;39:1141-8.
11. Ng KK, Lam CM, Poon RT, Shek TW, To JY, Wo YH, et al. Comparison of systemic responses of radiofrequency ablation, cryotherapy, and surgical resection in a porcine liver model. Ann Surg Oncol 2004;11:650-7.
12. Schell SR, Wessels FJ, Abouhamze A, Moldawer LL, Copeland EM, III. Pro- and antiinflammatory cytokine production after radiofrequency ablation of unresectable hepatic tumors. J Am Coll Surg 2002;195:774-81.
13. Badia JM, Ayton LC, Evans TJ, Carpenter AJ, Nawfal G, Kinderman H, et al. Systemic cytokine response to hepatic resections under total vascular exclusion. Eur J Surg 1998;164:185-90.
14. Lan AK, Luk HN, Goto S, Chen SM, Eng HL, Chen YS, et al. Stress response to hepatectomy in patients with a healthy or a diseased liver. World J Surg 2003;27:761-4.
15. Schroder J, Gallati H, Kremer B. Increased serum levels of soluble tumor necrosis factor a-receptors in patients undergoing partial liver resection. Hepatogastroenterology 1998;45:1807-12.
16. Seifert JK, Stewart GJ, Hewitt PM, Bolton EJ, Junginger T, Morris DL. Interleukin-6 and tumor necrosis factor-alpha levels following hepatic cryotherapy: association with volume and duration of freezing. World J Surg 1999;23:1019-26.
17. Zimmermann A. Liver regeneration: the emergence of new pathways. Med Sci Monit 2002;8:RA53-63.
18. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379-83.
19. Chijiiwa K, Saiki S, Tanaka M. Serum interleukin-6 and hepatocyte growth factor levels in patients after hepatectomy. Hepatogastroenterology 2002;49:467-71.
20. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci USA 1997;94:1441-6.
21. Matsumori A, Ono K, Furukawa Y, Okada M, Sasayama S. Circulating hepatocyte growth factor as an early marker of arterial thrombus formation. Jpn Circ J 1998;62:311-3.
22. Shimizu H, Miyazaki M, Wakabayashi Y, Mitsuhashi N, Kato A, Ito H, et al. Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. J Hepatol 2001;34:683-9.
23. Sato T, El-Assal ON, Ono T, Yamanoi A, Dhar DK, Nagasue N. Sinusoidal endothelial cell proliferation and expression of angiopoietin/Tie family in regenerating rat liver. J Hepatol 2001;34:690-8.
24. LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, Gerber HP, et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 2003;299:890-3.
25. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996;271:736-41.
26. Zhang YW, Su Y, Volpert OV, Vande Woude GF. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc Natl Acad Sci USA 2003;100:12718-23.
27. Sturm J, Keese M, Zhang H, Bonninghoff R, Magdeburg R, Vajkoczy P, et al. Liver regeneration in FGF-2-deficient mice: VEGF acts as potential functional substitute for FGF-2. Liver Int 2004;24:161-8.